Smith MR, Egerdie B, Hernandez Toriz N, et al, Denosumab HALT Prostate Cancer Study Group. Denosumab in men receiving androgen-deprivation therapy for prostate cancer. N Engl J Med. 2009, 361(8):745
Advertisement
Articles by Smith MR, Egerdie B, Hernandez Toriz N, et al, Denosumab HALT Prostate Cancer Study Group. Denosumab in men receiving androgen-deprivation therapy for prostate cancer. N Engl J Med. 2009, 361(8):745
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Andes Hantavirus FAQs: What to Know as Quarantined Cruise Passengers Return Home
2
New Therapies Offer Hope for Vitiligo, an Often Misunderstood and Undertreated Disease
3
FDA Issues Complete Response Letter for Cingulate's Once-Daily ADHD Drug CTx-1301
4
Rituximab Suppresses Clinical Relapses, MRI Activity in Pediatric MS
5